
Download Healthcare Quarterly Q3 2025
Preparing for Uncertainty: Medicaid Reform, Inflation, and Portfolio Alignment
The third quarter of 2025 marked a pivotal point for U.S. hospitals and health systems. While Moody’s 2024 medians confirmed steady improvement in operating performance, the broader environment grew more complex. The passage of the One Big Beautiful Bill Act (OBBBA) introduced the largest Medicaid funding reform in a decade, reducing federal contributions by nearly $1 trillion over the next 10 years and leaving rural and government-heavy systems facing heightened uncertainty.
At the same time, healthcare inflation continued to outpace the headline Consumer Price Index (CPI), and the Federal Reserve initiated its first rate cut of the cycle. Together, these shifts underscore the need for disciplined liquidity planning, portfolio alignment, and renewed attention to how investment strategy supports, not isolates from, the operating mission.
Moody’s 2024 Medians: Stabilization with Divergence
Moody’s 2024 medians reflected a healthcare sector regaining its footing. Operating cash-flow margins improved across all four U.S. regions, led by the South at 7.8 percent (up from 5.7 percent in 2023). The Midwest reported the strongest liquidity, with a median 216 days cash on hand, while the Northeast continued to trail in balance-sheet flexibility.
Beneath those averages, performance dispersion widened. Larger, diversified healthcare systems captured scale benefits and capital access, while stand-alone and rural hospitals remained constrained by payer mix and fixed cost intensity. The median trends signal stabilization, but not uniform recovery.
Medicaid Reform: The Uneven Impact of the OBBBA
The OBBBA restructures federal Medicaid participation and introduces a $50 billion Rural Health Transformation Fundintended to soften the blow of reduced reimbursements. However, one of the drawbacks being discussed is that half of the funds are projected to be distributed equally across states, regardless of rural population or need and that criteria is vague and may not prioritize the most vulnerable communities. The cuts (estimated between$1.0 and $1.1 trillionover ten years) will reverberate unevenly across geographies.
- Expansion States such as Kentucky, North Carolina, Illinois, Virginia, and New York will feel the sharper effect as enhanced federal matching phases down.
- Non-Expansion States, including Texas and Florida, may experience rising uncompensated-care burdens rather than direct funding loss.
- Rural Providers, already managing smaller volumes and higher fixed costs, will face the most acute pressure – one in four rural residents depends on Medicaid.
Early evidence suggests some states are beginning to respond. In late September, Massachusetts approved a $234 million funding packageto support hospitals serving rural and uninsured populations. Other states are likely to follow with similar supplemental measures to preserve access to care.
The policy’s timing allows systems a brief window to prepare. Scenario planning, liquidity mapping, and funding-source analysis will be critical in 2026 budget cycles as these changes begin to ripple through state reimbursements.
Healthcare Inflation: Costs Outrunning Prices
Despite easing headline inflation, healthcare expenses continue to climb faster than reimbursement. While overall CPI averaged roughly 3 percent this quarter, hospital-specific inflation hovered near 4 percent. Moreover, the Employment Cost Index, which captures wages and benefits, remained higher. For many operators, labor and benefit costs now exceed revenue growth, eroding recent margin gains.
Energy costs also emerged as a secondary concern. Data-center construction and grid strain have driven commercial utility inflation higher, adding incremental expense pressure to large hospital campuses. These dynamics reinforce the importance of maintaining investment allocations that preserve purchasing power over time.
Liquidity, De-Risking, and Portfolio Strategy
Highland emphasizes three disciplines for this environment:
- Cash Tiering: Define near-term, intermediate, and contingency liquidity horizons (typically 0–30 days, 1–6 months, and 6–12 months+) to align investment instruments with operating needs.
- Need-Based De-Risking: Model baseline, best-case, and worst-case reimbursement paths to ensure portfolio risk aligns with potential operational stress.
- Inflation-Sensitive Allocations: Considermaintaining exposure to private infrastructure and natural-resource equities (areas benefiting from energy-grid investment and global materials demand) to hedge healthcare-specific inflation that traditional CPI-linked assets may not capture.
Together, these strategies help ensure that portfolios remain a source of stability and liquidity rather than a potential liability when markets turn.
Looking Ahead
Q3 2025 showed encouraging financial progress, but rising external complexity. Margin gains, liquidity rebuilding, and market performance provided relief, yet policy reform, wage inflation, and energy costs will test that progress in 2026. The most resilient health systems will be those that integrate balance-sheet strategy with mission execution, linking investments, liquidity, and operations in one coherent framework.
Highland Associates remains focused on helping clients manage that alignment, turning financial discipline into strategic advantage.
IMPORTANT DISCLOSURES: This publication has been prepared by the staff of Highland Associates, Inc. for distribution to, among others, Highland Associates, Inc. clients. Highland Associates is registered with the United States Security and Exchange Commission under the Investment Advisors Act of 1940. Highland Associates is a wholly owned subsidiary of Regions Bank, which in turn is a wholly owned subsidiary of Regions Financial Corporation. Research services are provided through Multi-Asset Solutions, a department of the Regions Asset Management business group within Regions Bank. The information and material contained herein is provided solely for general information purposes only. To the extent these materials reference Regions Bank data, such materials are not intended to be reflective or indicative of, and should not be relied upon as, the results of operations, financial conditions or performance of Regions Bank. Unless otherwise specifically stated, any views, opinions, analyses, estimates and strategies, as the case may be (“views”), expressed in this content are those of the respective authors and speakers named in those pieces and may differ from those of Regions Bank and/or other Regions Bank employees and affiliates. Views and estimates constitute our judgment as of the date of these materials, are often based on current market conditions, and are subject to change without notice. Any examples used are generic, hypothetical and for illustration purposes only. Any prices/quotes/statistics included have been obtained from sources believed to be reliable, but Highland Associates, Inc. does not warrant their completeness or accuracy. This information in no way constitutes research and should not be treated as such. The views expressed herein should not be construed as individual investment advice for any particular person or entity and are not intended as recommendations of particular securities, financial instruments, strategies or banking services for a particular person or entity. The names and marks of other companies or their services or products may be the trademarks of their owners and are used only to identify such companies or their services or products and not to indicate endorsement, sponsorship, or ownership by Regions or Highland Associates. Employees of Highland Associates, Inc., may have positions in securities or their derivatives that may be mentioned in this report. Additionally, Highland’s clients and companies affiliated with Highland Associates may hold positions in the mentioned companies in their portfolios or strategies. This material does not constitute an offer or an invitation by or on behalf of Highland Associates to any person or entity to buy or sell any security or financial instrument or engage in any banking service. Nothing in these materials constitutes investment, legal, accounting or tax advice. Non-deposit products including investments, securities, mutual funds, insurance products, crypto assets and annuities: Are Not FDIC-Insured I Are Not a Deposit I May Go Down in Value I Are Not Bank Guaranteed I Are Not Insured by Any Federal Government Agency I Are Not a Condition of Any Banking Activity.
Neither Regions Bank nor Regions Asset Management (collectively, “Regions”) are registered municipal advisors nor provide advice to municipal entities or obligated persons with respect to municipal financial products or the issuance of municipal securities (including regarding the structure, timing, terms and similar matters concerning municipal financial products or municipal securities issuances) or engage in the solicitation of municipal entities or obligated persons for such services. With respect to this presentation and any other information, materials or communications provided by Regions, (a) Regions is not recommending an action to any municipal entity or obligated person, (b) Regions is not acting as an advisor to any municipal entity or obligated person and does not owe a fiduciary duty pursuant to Section 15B of the Securities Exchange Act of 1934 to any municipal entity or obligated person with respect to such presentation, information, materials or communications, (c) Regions is acting for its own interests, and (d) you should discuss this presentation and any such other information, materials or communications with any and all internal and external advisors and experts that you deem appropriate before acting on this presentation or any such other information, materials or communications.
Source: Bloomberg Index Services Limited. BLOOMBERG® is a trademark and service mark of Bloomberg Finance L.P. and its affiliates (collectively “Bloomberg”). BARCLAYS® is a trademark and service mark of Barclays Bank Plc (collectively with its affiliates, “Barclays”), used under license. Bloomberg or Bloomberg’s licensors, including Barclays, own all proprietary rights in the Bloomberg Barclays Indices. Neither Bloomberg nor Barclays approves or endorses this material or guarantees the accuracy or completeness of any information herein, or makes any warranty, express or implied, as to the results to be obtained therefrom and, to the maximum extent allowed by law, neither shall have any liability or responsibility for injury or damages arising in connection therewith.